Wednesday, April 22, 2020
FDA Regulatory Toolbox for COVID-19 Response;
Research Highlights: Remdesivir,
Hydroxychloroquine/Chloroquine;
Updates from the Front Lines: Florida & India
Presenters
![]() |
FDA Regulatory Toolbox for COVID-19 Response Elizabeth Sadove, JD Director of Medical Countermeasures Regulatory Policy, |
![]() |
Research Highlights: Remdesivir, Hydroxychloroquine & Chloroquine Charles McKay, MD, FACMT, FACEP Past President, American College of Medical Toxicology (ACMT) |
Updates From the Front Lines
![]() |
Miami Beach, FL David A. Farcy, MD, FAAEM, FCCM President, American Academy of Emergency Medicine (AAEM); |
![]() |
Chandigarh, India Ashish Bhalla, MD, FACMT President, Asia Pacific Association of Medical Toxicology (APAMT); |
Series Partners
American Academy of Clinical Toxicology (AACT) | American Academy of Emergency Medicine (AAEM) | American Association of Poison Control Centers (AAPCC) | American College of Medical Toxicology (ACMT) | Asia Pacific Association of Medical Toxicologists (APAMT) | European Association of Poison Centers and Clinical Toxicologists (EAPCCT) | Middle East & North Africa Clinical Toxicology Association (MENATOX)